Viewing Study NCT05176002


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2025-12-26 @ 2:32 AM
Study NCT ID: NCT05176002
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-19
First Post: 2021-11-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.
Sponsor: Fujian Medical University Union Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module